Skip to main content
. 2022 Jan 28;8:781648. doi: 10.3389/fsurg.2021.781648

Figure 4.

Figure 4

(A,B) Peak and LT day SCr of 90-day survivors and non-survivors in HRS-AKI stages 2 and 3. *P < 0.05. (C) CKD incidence curve of the HRS-AKI stage 3 group and HRS-AKI stages 1 and 2 group. (D) CKD incidence curve of HRS-AKI stage 1 group and HRS-AKI stages 2 and 3 group.